Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA vs OnabotulinumtoxinA in Neurogenic OAB
NCT03758235Phase 3Unknown
- Sponsor
- University of Perugia
- Start
- Sep 2018
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in neurogenic detrusor overactivity (NDO), sponsored by University of Perugia. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
neurogenic detrusor overactivity (NDO)
Beyond the preview
Go deeper on NCT03758235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03758235.